FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229056232> ?p ?o ?g. }

• W4229056232 abstract "We aimed to compare Australian health system costs at 12 months for adjuvant whole-brain radiotherapy (WBRT) treatment after stereotactic radiosurgery (SRS) and/or surgery versus observation among adults with one to three melanoma brain metastases. We hypothesized that treatment with adjuvant WBRT and subsequent healthcare would be more expensive than SRS/surgery alone.The analysis was conducted alongside a multicentre, randomized phase III trial. A bespoke cost questionnaire was used to measure healthcare use, including hospitalizations, specialist and primary care visits, imaging, and medicines over 12 months. Mean per-patient costs were calculated based on the quantity of resources used and unit costs, reported in Australian dollars ($AU), year 2018 values. Skewness of cost data was determined using normality tests and censor-adjusted costs reported using the Kaplan-Meier sample average method. The analysis of difference in mean costs at each 2-month time point and at 12 months was performed and checked using Kruskal-Wallis, generalized linear models with gamma distribution and log link, modified Park test, ordinary least squares, and non-parametric bootstrapping.In total, 89 patients with similar characteristics at baseline were included in the cost analysis (n = 43 WBRT; n = 46 observation). Hospitalization cost was the main cost, ranging from 63 to 89% of total healthcare costs. The unadjusted 12-monthly cost for WBRT was $AU71,138 ± standard deviation 41,475 and for observation $AU69,848 ± 33,233; p = 0.7426. The censor-adjusted 12-monthly cost for WBRT was $AU90,277 ± 36,274 and $AU82,080 ± 34,411 for observation. There was no significant difference in 2-monthly costs between groups (p > 0.30 for all models).Most costs were related to inpatient hospitalizations associated with disease recurrence. Adding WBRT after local SRS/surgery for patients with one to three melanoma brain metastases did not significantly increase health system costs during the first 12 months.ACTRN12607000512426, prospectively registered 14 September 2007." @default.
• W4229056232 created "2022-05-08" @default.
• W4229056232 creator A5034265780 @default.
• W4229056232 creator A5034982958 @default.
• W4229056232 creator A5064952058 @default.
• W4229056232 creator A5083765822 @default.
• W4229056232 creator A5085605664 @default.
• W4229056232 creator A5089097733 @default.
• W4229056232 creator A5090390499 @default.
• W4229056232 date "2022-05-05" @default.
• W4229056232 modified "2023-10-12" @default.
• W4229056232 title "Cost Analysis of Adjuvant Whole-Brain Radiotherapy Treatment Versus No Whole-Brain Radiotherapy After Stereotactic Radiosurgery and/or Surgery Among Adults with One to Three Melanoma Brain Metastases: Results from a Randomized Trial" @default.
• W4229056232 cites W1813879195 @default.
• W4229056232 cites W1976873809 @default.
• W4229056232 cites W1988375101 @default.
• W4229056232 cites W2059476232 @default.
• W4229056232 cites W2061455688 @default.
• W4229056232 cites W2070259449 @default.
• W4229056232 cites W2083812156 @default.
• W4229056232 cites W2091640226 @default.
• W4229056232 cites W2094121640 @default.
• W4229056232 cites W2096313377 @default.
• W4229056232 cites W2140752328 @default.
• W4229056232 cites W2415629219 @default.
• W4229056232 cites W2470100784 @default.
• W4229056232 cites W2492450141 @default.
• W4229056232 cites W2739553701 @default.
• W4229056232 cites W2792783941 @default.
• W4229056232 cites W2964429012 @default.
• W4229056232 cites W2969314258 @default.
• W4229056232 cites W2973889452 @default.
• W4229056232 cites W3012525535 @default.
• W4229056232 doi "https://doi.org/10.1007/s41669-022-00332-8" @default.
• W4229056232 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35513735" @default.
• W4229056232 hasPublicationYear "2022" @default.
• W4229056232 type Work @default.
• W4229056232 citedByCount "0" @default.
• W4229056232 crossrefType "journal-article" @default.
• W4229056232 hasAuthorship W4229056232A5034265780 @default.
• W4229056232 hasAuthorship W4229056232A5034982958 @default.
• W4229056232 hasAuthorship W4229056232A5064952058 @default.
• W4229056232 hasAuthorship W4229056232A5083765822 @default.
• W4229056232 hasAuthorship W4229056232A5085605664 @default.
• W4229056232 hasAuthorship W4229056232A5089097733 @default.
• W4229056232 hasAuthorship W4229056232A5090390499 @default.
• W4229056232 hasBestOaLocation W42290562321 @default.
• W4229056232 hasConcept C141071460 @default.
• W4229056232 hasConcept C168563851 @default.
• W4229056232 hasConcept C2780387249 @default.
• W4229056232 hasConcept C2989005 @default.
• W4229056232 hasConcept C509974204 @default.
• W4229056232 hasConcept C71924100 @default.
• W4229056232 hasConceptScore W4229056232C141071460 @default.
• W4229056232 hasConceptScore W4229056232C168563851 @default.
• W4229056232 hasConceptScore W4229056232C2780387249 @default.
• W4229056232 hasConceptScore W4229056232C2989005 @default.
• W4229056232 hasConceptScore W4229056232C509974204 @default.
• W4229056232 hasConceptScore W4229056232C71924100 @default.
• W4229056232 hasLocation W42290562321 @default.
• W4229056232 hasLocation W42290562322 @default.
• W4229056232 hasLocation W42290562323 @default.
• W4229056232 hasOpenAccess W4229056232 @default.
• W4229056232 hasPrimaryLocation W42290562321 @default.
• W4229056232 hasRelatedWork W2002120878 @default.
• W4229056232 hasRelatedWork W2003938723 @default.
• W4229056232 hasRelatedWork W2039831062 @default.
• W4229056232 hasRelatedWork W2047967234 @default.
• W4229056232 hasRelatedWork W2118496982 @default.
• W4229056232 hasRelatedWork W2156028401 @default.
• W4229056232 hasRelatedWork W2439875401 @default.
• W4229056232 hasRelatedWork W4238867864 @default.
• W4229056232 hasRelatedWork W2519357708 @default.
• W4229056232 hasRelatedWork W2525756941 @default.
• W4229056232 isParatext "false" @default.
• W4229056232 isRetracted "false" @default.
• W4229056232 workType "article" @default.